Programme Description
The joint fellowship between ECTRIMS and the MOGAD Eugene Devic European Network (MEDEN) aims to foster collaboration and research among clinicians and scientists across Europe, focusing on neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte antibody associated disorder (MOGAD). The selected projects will be part of a multi-centre effort, open to all MEDEN sites, which allows fellows to engage with leading European experts in the field.
Each year, the MEDEN Committee will establish a priority research theme to guide applicants in their proposals, ensuring that research efforts align with the most urgent needs in the specialty. A jury, consisting of MEDEN leaders and an ECTRIMS representative, will select the fellowship recipient after a thorough review of applications in January 2025. The inaugural fellowship, sponsored by The Sumaira Foundation and Alexion AstraZeneca Rare Disease, will last one to two years.
Targeted project for 2025: A cross-sectional analysis of the European MEDEN NMOSD and MOGAD patients
The application period for the 2025 cycle will open on 15 July 2024.
